Average daily Aadhaar-enabled transactions double; Rs 16,101 cr disbursed during lockdown: FinMin
Average daily transactions through the Aadhaar-enabled payment system (AePS) has doubled to Rs 113 crore
New Delhi: Average daily transactions through the Aadhaar-enabled payment system (AePS) has doubled to Rs 113 crore on account of various direct benefit transfer schemes announced by the government during the coronavirus-induced lockdown.
As many as 43 crore transactions leading to disbursement of Rs 16,101 crore took place during the lockdown period, the finance ministry said in a tweet on Monday.
Avg. daily AePS transactions doubled to 113 Lakh: Total 43 Cr. transactions of Rs. 16,101 Cr. made during the lockdown. DFS Congratulates the whole banking system & lauds BCs/CSPs for making it possible by providing services via biometric devices even in remote areas @FinMinIndia pic.twitter.com/6AsapLBCgR
— DFS (@DFS_India) May 4, 2020
AePS is a bank-led model that allows online interoperable financial transactions at points of sale or micro ATMs through the business correspondents (BC) or Bank Mitras of any bank using the Aadhaar authentication.
With the help of this system, doorstep delivery of cash can take place through BCs.
To contain the spread of coronavirus, the government first imposed a 21-day nationwide lockdown beginning 25 March and later extended it till 3 May. Now, it has further extended the lockdown by two more weeks till 17 May with extensive relaxations, including opening of industries in lower-risk green and orange zones.
The nationwide lockdown shut businesses, stopped air and rail travel and restricted movement of people and goods.
The National Capital had logged 11,684 Covid cases and 38 deaths due to the disease on Tuesday, while the positivity rate had declined to 22.47 per cent
Stressing the need to continue with precautions to curb the surge in infections, it noted that Karnataka, Kerala, Tamil Nadu, Gujarat, Andhra Pradesh, Rajasthan were recording a high number of COVID cases
Under the conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting besides recording all vaccinations done within the country on the CoWIN platform, the sources said